Cloning and expression of .beta.APP-C100 receptor (C100-R)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6083713
SERIAL NO

08559397

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the cloning of .beta.APP-C100 receptor (C100-R), and genetically engineered host cells which express the C100-R. Such engineered cells may be used to evaluate and screen drugs and analogs of .beta.-APP involved in Alzheimer's Disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MCLEAN HOSPITAL CORPORATION115 MILL STREET BELMONT MA 03478

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kozlowski, Michael R Palo Alto, CA 14 189
Manly, Susan P Wallingford, CT 5 11
Neve, Rachael L Belmont, MA 4 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation